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CASE REPORT
Lucio’s phenomenon, an uncommon 
occurrence among leprosy patients in Sri Lanka
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Abstract 
Background: Lucio’s phenomenon is a rare manifestation of untreated leprosy which is seen almost exclusively in 
regions surrounding the Gulf of Mexico. Its occurrence elsewhere though documented is considered uncommon. We 
present a case of Lucio’s phenomenon in a previously undiagnosed leprosy patient who presented to us with its clas-
sical skin manifestations.
Case presentation: A 64 year old South Asian (Sri Lankan) male with a history of chronic obstructive airway disease 
presented to us with fever and cough. He had a generalized smooth and shiny skin with ulcerating skin lesions afflict-
ing the digits of the fingers. The lesions progressed to involve the extremities of the body and healed with crusting. 
Based on the clinical and investigational findings Tuberculosis and common vasculitic conditions were suspected and 
excluded. The unusual skin manifestations prompted a biopsy, and wade fite stained revealed Mycobacterium bacilli. 
In context of the clinical picture and histological findings, Lucio’s phenomenon was suspected. A clinical diagnosis of 
Lucio’s phenomenon occurring in the backdrop of lepromatous leprosy was made.
Conclusion: Though leprosy is still a prevalent disease, it has manifestations that are not easily recognized or fully 
appreciated. Regional patterns of atypical manifestations should not limit better understanding of rarer manifesta-
tions as it will aid in clinching an early diagnosis and instituting prompt treatment, thereby reducing morbidity and 
mortality.
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Background
Hansen’s disease or leprosy is a chronic infectious dis-
ease caused by Mycobacterium leprae. The clinical course 
depends on the immune response mounted by the host. 
The presentation of infection shows a spectrum from 
tuberculoid to that of lepromatous versions of the illness 
[1]. Leprosy patients tend to have reactions based on the 
pattern of immune response elicited and depending on 
the mechanism these are further subcategorized. Lucio’s 
phenomenon is one such manifestation. First described 
in detail by Lucio and Alvarado and further elaborated 
by Latapi and Franken nearly a century later, Lucio’s phe-
nomenon is a rare form of reaction seen in pure lepro-
matous leprosy (LL) or borderline lepromatous leprosy 
(BL) [2–4]. Some consider this entity a separate form of 
leprosy and define it as Lucio’s leprosy [5, 6] and attribute 
it to a newly discovered species, M. lepromatosis [7, 8]. 
Leprosy is still a globally prevalent disease [9], but seen in 
higher incidence in developing countries [10]. However 
Lucio’s phenomenon is a rare presentation seen exclu-
sively in Mexico and Central America and is considered 
a globally restricted phenomenon [5, 11, 12]. But with 
increased recognition cases are being reported sporadi-
cally worldwide from South Asian and South East Asian 
countries [10, 13, 14], South Pacific-Polynesian islands 
[15], the Middle east and even African nations [9, 16–18] 
and thus should be suspected when clinically relevant 
even in non-endemic countries [19]. We present a rare 
occurrence of Lucio’s phenomenon, in a previously undi-
agnosed patient with lepromatous leprosy.
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Case presentation
A 64 year old South Asian (Sri Lankan) man from a poor 
socio economic class who was previously diagnosed with 
chronic obstructive pulmonary disease (COPD) pre-
sented with an exacerbation of COPD with a produc-
tive cough of 2  weeks duration and recent onset fever. 
He also noted a recent swelling of both upper limbs that 
began during the same time period. He additionally com-
plained of constitutional symptoms with loss of appetite 
with resultant loss of weight occurring over 6  month’s 
duration. He was a heavy smoker with 40 pack years, 
but has abstained for the last 5 years. He otherwise had 
no high risk behaviours and denied any prior history of 
joint, bowel or skin diseases. On general examination he 
was afebrile but clinically dehydrated and had pallor. His 
skin had a smooth sheen and felt very thin to touch. Both 
hands were oedematous and areas of necrosis were seen 
on the fingers. While warded in hospital his skin manifes-
tations progressed. The lesions were seen predominantly 
below elbow and knees. He developed ulcerations, which 
were superficial demonstrating healthy granulation tis-
sue, slough and areas of necrosis involving the dorsal 
surface of the extremities of both upper and lower limbs 
as well as the pinnae which healed with honey colored 
crusts (Fig. 1). Respiratory system examination revealed 
few bilateral crepitations. Examination of the abdominal, 
and cardiovascular systems failed to reveal significant 
abnormality. Neurological examination demonstrated a 
glove and stocking type peripheral sensory neuropathy 
for both soft touch and pain sensation. Similarly vibra-
tion was also noted to be diminished. Furthermore, bilat-
eral thickening of the ulnar nerves were also noted on 
palpation.
Whole blood analysis revealed severe anaemia with a 
haemoglogin of 5.9  g/dL (11–18) with a mean corpus-
cular volume (MCV) of 60 fL (80–100) and a mean cor-
puscular haemoglobin (MCH) of 17.8 pG (27–34). White 
cell count (WCC) was normal with a value of 9.8. × 109/L 
(4–10) with a predominant neutrophillic count of 80 %. 
Platelets were elevated to a value of 522 × 109/L (150–
450). Blood picture reflected the whole blood analysis 
with toxic changes seen with a neutrophil leukocytosis 
favouring an ongoing bacterial infection and reactive 
thrombocytosis. Iron studies revealed reduced serum 
iron with a value of 15  µg/dL (41–132) with reduced 
iron saturation of 7.8 % (15–35) and a reduced total iron 
binding capacity of 192  µg/dL (228–428) suggestive of 
anaemia of chronic disease. Serum ferritin was elevated 
at 539  ng/ml (20–400). Preliminary liver enzymes were 
normal as was the bilirubin level. Serum proteins were 
elevated with a value of 88 g/L (61–77) with a predomi-
nant globulin fraction with 53  g/L (22–40). Serum pro-
tein electrophoresis demonstrated marked poly-clonal 
gammopathy with prominent alpha 1 & 2 bands and 
markedly diminished albumin levels. Erythrocyte sedi-
mentation rate (ESR) was very high with a value of 
149  mm for the 1st hour (<15) and similarly C-reactive 
protein was elevated to a value of 167 mg/L (<8). Serum 
lactate dehydrogenase was normal with a value of 260 
U/L (230–460). Fasting blood sugar was normal. Spu-
tum was checked for acid fast bacilli (AFB) as the patient 
presented with a chronic cough and it revealed the pres-
ence of abundant acid fast bacilli although sputum for 
Mycobacterium tuberculosis polymerase chain reaction 
(PCR) and culture were negative. Imaging of the chest 
with plain chest X-ray and high resolution contrast CT 
were failed to detect significant abnormality despite the 
positive acid fast bacilli found in sputum. Anti-nuclear 
antibodies, anti-neutrophil cytoplasmic auto antibodies 
P and C, rheumatoid factor, cryoglobulin were all nega-
tive and complement 3 and complement 4 levels were 
normal. VDRL, Hepatitis B surface antigen, Hepatitis C 
antibodies and human immunodeficiency virus antibody 
I and II were negative. Blood and urinary cultures failed 
to reveal a growth. Upper gastrointestinal endoscopy 
revealed erosive esophagitis with multiple small ulcers 
all over the body of the stomach and the presence of 
duodenitis. Skin biopsy revealed clusters of foamy mac-
rophages within the dermis and wade fite stained posi-
tive for Mycobacterium bacilli. Focal necrosis was also 
seen in the epidermis. A slit skin smear showed a bac-
illary index of +4 (indicating at least 10 bacilli in every 
field).The histology demonstrated the presence of throm-
bosed capillary vessels in the absence of inflammatory 
cells, though panniculitis was not noted on the analyzed 
specimen, in context with the clinical picture Lucio’s lep-
rosy was favored as the diagnosis (Fig.  2). PCR for M. 
tuberculosis of the bone marrow was negative. A clinical 
diagnosis of Lucio’s phenomenon secondary to leproma-
tous leprosy was made and multi drug therapy regimen 
was started. As the patient had already been transfused 
with blood since he was severely anaemic and emaciated 
Glucose-6-phosphate-dehydragenase (G6PD) enzyme 
levels were not checked and dapsone was withheld from 
the treatment regimen. Thus the patient was started on 
daily doses of clofazimine with ofloxacin together with 
monthly high dose rifampicin and clofazimine according 
to guidelines on the management of lepromatous leprosy. 
The patient developed secondary skin infection in the 
affected areas, with resultant fever. In ward therapy was 
carried out till patient showed clinical improvement. Fre-
quent cleaning and dressing of the ulcerated areas of the 
limbs and digits were done under antibiotic cover. Sup-
portive therapy was also incorporated with high protein 
and caloric diet along with intravenous albumin infusion 
along with rehabilitation and physiotherapy. The patient 
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demonstrated satisfactory response to treatment with 
resolution of secondary local sepsis and visible clinical 
recovery was also seen with the onset of healing of ulcers 
due to Lucio’s phenomenon.
Discussion
The patient in this case study presented with fever and 
in the background of COPD the initial working diagno-
sis was that of a respiratory tract infection complicating 
Fig. 1 Skin manifestations of Lucio’s phenomenon observed. The first row depicts, bizarre shaped well demarcated superficial ulceration with 
slough formation (left image), which following treatment resulted in healing with cicatrization (middle and right images) The second row shows 
large denuded areas secondary to ulceration and necrosis of the foot (left and middle) finally resolving with cicatrization (right image). The third 
row depicts symmetrical involvement of the lower limbs (left) and upper limbs (right) with extensive bizarre ulceronecrosis. The fourth row depicts 
diffuse facial involvement with shiny skin, madarosis and infiltration with nodules in the chin (left) with involvement of the ear with necrotic lesions 
associated with crusting (middle) and mild truncal involvement with hairless shiny skin (right)
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COPD. However a high ESR with a history of chronic 
cough in a country endemic to tuberculosis, prompted 
us to exclude pulmonary tuberculosis (PTB). Though our 
suspicion was strengthened by the sputum analysis dem-
onstrating AFB, the negative PCR analysis and culture 
along with the lack findings favoring PTB on chest imag-
ing caused clinical confusion. Furthermore our initial 
assumption of a dual pathology for his skin manifestation 
due to vasculitic type lesions prompted further investi-
gations to exclude usual causative agents with serologi-
cal studies, and biopsy was taken akin for this purpose. 
Though leprosy was entertained in the differential diag-
nosis the obscure nature of this specific manifestation did 
not immediately direct us towards its diagnosis. But the 
skin biopsy helped us finally clinch a unifying diagnosis 
in context of the clinical presentation of Lucio’s phenom-
enon secondary to lepromatous leprosy. Though he never 
had continuous follow up for COPD, the lack of aware-
ness among the general populace and possibly clinicians 
who may have been consulted previously is demonstrated 
by the late identification of his advanced state of leprosy. 
This goes to demonstrate that despite being a country 
afflicted by leprosy its rarer manifestations are still not 
fully appreciated.
Lucio’s phenomenon is a reactional state and is thought 
to occur in the lepromatous version of the illness where 
the unresponsiveness of the immune system allows unre-
stricted proliferation of Mycobacterium lepromatosis sp. 
nov, a newly discovered species with traits that allow it 
to manifest distinct clinic-pathological features more 
towards the diffuse end of the spectrum of the disease 
[2, 7, 8, 19, 20]. Lucio’s phenomenon may present as a 
new feature in an already well-established, yet untreated 
leprosy patient. It can also be the preliminary symp-
tom introducing the lepromatous version of the disease. 
Rarely, it can present in an already fully treated diffuse 
lepromatous leprosy patient in the absence of bacilli, 
even years later [4, 5, 15, 16].
The cutaneous manifestations of Lucio’s may be dif-
ficult to identify as the skin manifestations tend to be 
diffuse and variable. But its propensity to cause signifi-
cant morbidity and scarring with possible fatal outcome 
Fig. 2 Histology of the skin biopsy. Image (1) depicts wade fite stain demonstrating the presence of (red) bacilli (indicated by arrow) within foamy 
cells and endothelial cells. Image (2) demonstrates blood vessels (indicated by arrow) with associated endothelial swelling. Image (3) shows pres-
ence of necrosis and ulceration of epidermis without panniculitis. Image (4) depicts endothelial proliferation and capillary thrombosis (indicated by 
arrow)
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stresses the importance of early identification of this 
treatable condition [5, 21]. The skin manifestations clas-
sically occur in the absence of constitutional symptoms 
and include generalized dryness and shininess, with a 
myxedematous appearance, thus being called “lepra-
bonita or pretty leprosy”. There may also be hair loss with 
resultant alopecia involving the eyebrows, eyelashes and 
other areas of body hair. The ongoing vasculitic process 
causes either defined and or irregular erythematous spots 
with painless hemorrhagic blisters. These can evolve into 
necrotic areas with scabs and ulcerate with angular mar-
gins causing pain. Though there is a predilection for the 
extremities, the affected area can be diffuse and involve 
the trunk and the face [12, 19]. The lesions can recur 
and have a destructive effect especially when afflicting 
superficial regions of the body e.g., pinna, nose. The dis-
ease process may involve the subcutaneous tissue due to 
the erosive process and cause significant scarring. If the 
involvement is severe the ischaemic necrosis of the skin 
can result in detachment [2, 4, 12, 16, 21–25]. Though 
fever may not be part of primary spectrum of the disease, 
secondary sepsis may herald its onset. Our patient in 
hindsight demonstrated most of these classical manifes-
tations and pattern of presentation (Fig. 1).
A commonly encountered problem is that Lucio’s may 
be confused with erythema nodosum with necrosis, 
which Bernard and colleagues help differentiate [24]. 
Accordingly, our patients skin manifestations occurred 
in the pure primitive and diffuse form of leprosy, prior 
to initiating treatment with typical irregularly shaped 
superficial ulcers followed by crusting, clinically favored 
Lucio’s more than erythema nodosum with necrosis. 
Furthermore, histologically the absence of inflamma-
tory infiltrate together with the presence of thrombosed 
vessels of the superficial dermis associated with necro-
sis also favored Lucios. The presence of fever was atypi-
cal, but maybe attributable to a respiratory infection 
complicating COPD. Thus, based on the classical skin 
manifestation, the advanced stage of the disease and the 
histological findings of thrombosed vessels in the absence 
of neutrophillic infiltrates (Fig. 2) our patients’ diagnosis 
favors that of Lucio’s.
Early diagnosis and prompt treatment is beneficial as it 
can improve outcome [14]. Overall response to treatment 
may be seen rapidly, between 1 week to 1 month follow-
ing initiation of microbicidal drug treatment [26]. The 
pure form of Lucio’s may only necessitate the usual multi 
drug regimen. Thus making the usual anti-leprosy drugs 
an effective first line treatment [15] without requiring 
thalidomide or systemic corticosteroids to be included 
into the regimen [6, 27], though these have also been 
opted to be used in severe situations and found useful 
[21]. However, fatality has been seen despite aggressive 
treatment [28]. This is attributable to secondary infection 
and sepsis due to the presence of a susceptible of skin 
condition, poor nutritional status, opted treatment regi-
mens [19] and delay in diagnosis or misdiagnosis [22].
Our patient required an urgent blood transfusion 
prior to a definitive diagnosis, thus G6PD levels were not 
checked as the lab interpretation would not be accurate, 
so to err on the side of caution the patient was not initi-
ated on dapsone. Instead ofloxacin was substituted along 
with the remainder of the multi-bacillary regimen in 
accordance to guidelines on treatment. Supportive meas-
ures were undertaken with the institution of high protein 
diet, rehabilitation and physiotherapy. Frequent wound 
dressing along with the initiation of antibiotics to con-
trol secondary infection helped quicken the resolution. 
The patient showed improvement with treatment and 
this was sustained on review a month following discharge 
from hospital (Fig. 1).
Conclusion
Though leprosy is not uncommon, Lucio’s is a rare pres-
entation. If encountered in the absence of familiarity, 
diagnosis may be unduly delayed. Clinicians should be 
wary of even rare presentations of commonly encoun-
tered diseases like leprosy despite their uncommon inci-
dence due to regional patterns of prevalence. Lack of 
awareness may be the reason why phenomena such as 
Lucio’s are under diagnosed, unreported and remain in 
obscurity.
Consent
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